Maldives

Diabetes estimates (20-79 y)
People with diabetes, in 1,000s	-	15.2	30.9	53.2
Age-standardised prevalence of diabetes, %	-	9.2	9.5	10.5
Proportion of people with undiagnosed diabetes, %	-	-	28.2	-
People with undiagnosed diabetes, in 1,000s	-	-	8.7	-

Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s	-	-	37.4	49.5
Age-standardised prevalence of IFG, %	-	-	10.3	10.7

Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s	-	8.5	43.2	54.8
Age-standardised prevalence of IGT, %	-	4.8	11.6	12.4

Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes	-	141.0	33.1	-
Proportion of diabetes-related deaths in people 20-79 y, %	-	-	4.6	-

Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP	-	-	-	-
Prevalence of gestational diabetes mellitus (GDM), %	-	-	-	-
Live births affected by other types of diabetes first detected in pregnancy	-	-	-	-
Live births affected by other types of diabetes detected prior to pregnancy	-	-	-	-

Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million	-	-	50.1	59.0
Total diabetes-related health expenditure, ID million	-	-	74.2	87.5
Diabetes-related health expenditure per person, USD	-	803.0	1,619.3	1,109.4
Diabetes-related health expenditure per person, ID	-	-	2,399.4	1,643.9

Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups)	-	-	485.0	-
People with type 1 diabetes (0-19 y)	-	-	109.7	-

Demographics
Total adult population (20-79 y), in 1,000s	-	198.9	369.1	438.3
Population of children and adolescents (0-19 y)	-	-	135,759.5	-